Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5748 | 2021 |
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1425 | 2021 |
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021 | 782 | 2021 |
Assessing the environmental impacts of mega sporting events: Two options? A Collins, C Jones, M Munday Tourism management 30 (6), 828-837, 2009 | 598 | 2009 |
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised … X Liu, RH Shaw, ASV Stuart, M Greenland, PK Aley, NJ Andrews, ... The Lancet 398 (10303), 856-869, 2021 | 527 | 2021 |
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) A Flaxman, NG Marchevsky, D Jenkin, J Aboagye, PK Aley, B Angus, ... The Lancet 398 (10304), 981-990, 2021 | 292 | 2021 |
Guest editorial: Perspectives on sustainable consumption K Peattie, A Collins International Journal of Consumer Studies 33 (2), 107-112, 2009 | 278 | 2009 |
Assessing the environmental consequences of major sporting events: The 2003/04 FA Cup Final A Collins, A Flynn, M Munday, A Roberts Urban studies 44 (3), 457-476, 2007 | 269 | 2007 |
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a … ASV Stuart, RH Shaw, X Liu, M Greenland, PK Aley, NJ Andrews, ... The Lancet 399 (10319), 36-49, 2022 | 243 | 2022 |
Tuberculosis at extremes of age HS Schaaf, A Collins, A Bekker, PDO Davies Respirology 15 (5), 747-763, 2010 | 220 | 2010 |
Controlled Human Infection and Rechallenge with Streptococcus pneumoniae Reveals the Protective Efficacy of Carriage in Healthy Adults DM Ferreira, DR Neill, M Bangert, JF Gritzfeld, N Green, AKA Wright, ... American journal of respiratory and critical care medicine 187 (8), 855-864, 2013 | 209 | 2013 |
Measuring and managing the environmental impact of festivals: The contribution of the Ecological Footprint A Collins, C Cooper Journal of Sustainable Tourism 25 (1), 148-162, 2017 | 185 | 2017 |
Measuring the environmental sustainability of a major sporting event: A case study of the FA Cup Final A Collins, A Flynn Tourism Economics 14 (4), 751-768, 2008 | 161 | 2008 |
Oxford COVID Vaccine Trial Group Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... Lancet 397 (10269), 99-111, 2021 | 143 | 2021 |
Sustainable food consumption at a sub-national level: an ecological footprint, nutritional and economic analysis A Collins, R Fairchild Journal of Environmental Policy & Planning 9 (1), 5-30, 2007 | 138 | 2007 |
Learning and teaching sustainability: The contribution of Ecological Footprint calculators A Collins, A Galli, N Patrizi, FM Pulselli Journal of Cleaner Production 174, 1000-1010, 2018 | 131 | 2018 |
Environmental consequences of tourism consumption at major events: An analysis of the UK stages of the 2007 Tour de France A Collins, M Munday, A Roberts Journal of Travel Research 51 (5), 577-590, 2012 | 129 | 2012 |
The environmental impacts of consumption at a subnational level A Collins, A Flynn, T Wiedmann, J Barrett Journal of Industrial Ecology 10 (3), 9-24, 2006 | 129 | 2006 |
Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung AKA Wright, M Bangert, JF Gritzfeld, DM Ferreira, KC Jambo, AD Wright, ... PLoS pathogens 9 (3), e1003274, 2013 | 123 | 2013 |
Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage E Mitsi, AM Roche, J Reiné, T Zangari, JT Owugha, SH Pennington, ... Mucosal immunology 10 (2), 385-394, 2017 | 106 | 2017 |